Picture of Celadon Pharmaceuticals logo

CEL Celadon Pharmaceuticals Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-22.8%
3m-23.9%
6m-38.62%
1yr-31.85%
Volume Change (%)
10d/3m+80.62%
Price vs... (%)
52w High-53.7%
50d MA-10.81%
200d MA-26.51%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value18.66
Price to Tang. Book21.34
Price to Free Cashflown/a
Price to Sales2,708.91
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-88.57%
Return on Equity-114.01%
Operating Margin-34440.02%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Celadon Pharmaceuticals EPS forecast chart

Profile Summary

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism. The Company's facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    June 30th, 2023
    Incorporated
    August 31st, 2018
    Public Since
    October 19th, 2018
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    64,208,903

    CEL Share Price Performance

    Upcoming Events for CEL

    Full Year 2024 Celadon Pharmaceuticals PLC Earnings Release

    Half Year 2024 Celadon Pharmaceuticals PLC Earnings Release

    Celadon Pharmaceuticals PLC Annual Shareholders Meeting

    Similar to CEL

    Picture of Alliance Pharma logo

    Alliance Pharma

    gb flag iconLondon Stock Exchange

    Picture of Animalcare logo

    Animalcare

    gb flag iconLondon Stock Exchange

    Picture of AstraZeneca logo

    AstraZeneca

    gb flag iconLondon Stock Exchange

    Picture of Beximco Pharmaceuticals logo

    Beximco Pharmaceuticals

    gb flag iconLondon Stock Exchange

    Picture of BSF Enterprise logo

    BSF Enterprise

    gb flag iconLondon Stock Exchange

    FAQ